New AI Tool ARTEMIS Shows Promise for Noninvasive Cancer Testing and Insights
-
ARTEMIS is a new machine learning tool that identifies repeat DNA sequences in cancer cells, enabling noninvasive diagnosis and insights into cancer genetics.
-
ARTEMIS examines over 1,200 types of repeat elements comprising nearly half of the human genome. Many repeats not previously tied to cancer were altered in tumors.
-
In tests, ARTEMIS distinguished tumors from normal tissues with high accuracy across cancer types and scores were linked to survival.
-
When combined with another test called DELFI, ARTEMIS detected multiple cancer types from blood with 68-91% accuracy and identified tumor location with up to 83% accuracy.
-
Next steps are larger trials for early detection, treatment monitoring, and recurrence detection across cancer types.